Ann: Annual Report to shareholders, page-26

From here i think there is limited news which would make this stock really such as:-

- agreement with US multinational
- early release of positive clinical trial results
- some how a large increase in sales volume (least likely to occur in short period of time)

I think the AGM will be the usual fluff which has been served up to share holders for the last couple of years.

As i dont hold any options i am very content/happy for this stock to sit low to allow (at the very least) the first wave of options to expire without being exercised ...

no one wins buy having another 100 mil of shares released on market - especially when a big chunck of them will be Pattersen's !!